Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
Antonella Bresin, Cristina Cristofoletti, Elisabetta Caprini, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 5, pp. 1045-1053.e6
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
Carla Navarro, Ángel Ortega, Raquel Santeliz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1303-1303
Open Access | Times Cited: 79
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
Tithi Roy, Samuel Boateng, Mohammad B. Uddin, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1671-1671
Open Access | Times Cited: 52
Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
Fani Karagianni, Antreas Pavlidis, Lina S. Malakou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1693-1693
Open Access | Times Cited: 54
Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment
William Nguyen, Lauren P. Chrisman, Gail L. Enriquez, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?
Chiara Tarantelli, Antonio Lupia, Anastasios Stathis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1060-1060
Open Access | Times Cited: 34
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway
Marta Banchi, Maria Christina Cox, Arianna Bandini, et al.
Investigational New Drugs (2025)
Closed Access
HDAC10 and its implications in Sézary syndrome pathogenesis
Monika Pieniawska, Karolina Rassek, Bogumiła Skwara, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
Ajay Major, Justin Kline, Theodore Karrison, et al.
Haematologica (2021) Vol. 107, Iss. 7, pp. 1608-1618
Open Access | Times Cited: 25
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Hua Yang, Yang Xun, Chao Ke, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 6
Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment
Megha Yadav, Blessi N. Uikey, Shantnu Singh Rathore, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells
Zaozao Wang, Bin Kang, Qianqian Gao, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3895-3910
Open Access | Times Cited: 11
ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma
Mengzhou Cao, Pan Lai, Xiangjun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma
Chen‐Hui Luo, Lihong Hu, Jie-Yang Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
Makoto Sugaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11079-11079
Open Access | Times Cited: 6
Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far
Antonella Bresin, Elisabetta Caprini, Giandomenico Russo, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 6, pp. 1533-1540
Open Access | Times Cited: 4
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial
Selinde Wind, Manon A. A. Jansen, M. Rijsbergen, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1510-1510
Open Access | Times Cited: 3
Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides
Zachary A. Bordeaux, Sriya V. Reddy, Justin Choi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
“Next top” mouse models advancing CTCL research
Yixin Luo, Frank R. de Gruijl, Maarten H. Vermeer, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
CDK9 recruits HUWE1 E3 ligase to degrade RARα in a kinase independent manner and offers therapeutic opportunities for cutaneous T-cell lymphoma
Ying Lu, Chen‐Hui Luo, Lihong Hu, et al.
Research Square (Research Square) (2024)
Open Access
DEPTOR levels in patients with mycosis fungoides
Aslı Aksu Çerman, Ceylan Bulat, Pınar Özdemir Çetinkaya, et al.
Dermatologica Sinica (2024)
Open Access
Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
Cristina Cristofoletti, Antonella Bresin, Martina Fioretti, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2847-2847
Open Access | Times Cited: 2
Essential role of 4E-BP1 for lymphocyte activation and proliferation in the adaptive immune response of Nile tilapia
Li Cheng, Kang Li, Kunming Li, et al.
Fish and Shellfish Immunology Reports (2021) Vol. 2, pp. 100006-100006
Open Access | Times Cited: 2
Binding site hotspot map of PI3Kα and mTOR in the presence of selective and dual ATP-competitive inhibitors
Francisca Fernanda Nunes Azevedo, Francisca Joseli Freitas de Sousa, Francisco Lucas Santos de Oliveira, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 41, Iss. 3, pp. 1085-1097
Closed Access | Times Cited: 2
DEPTOR levels in patients with mycosis fungoides
Aslı Aksu Çerman, Ceylan Bulat, Pınar Özdemir Çetinkaya, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top